Oral Administration of Antibiotics and Intestinal Flora Associated Endotoxin in Mice

References

• Butler D A, Lobrefat C M, Gavan T L. Reproducibility of the Analytab (API 20E) system. J Clin Microbiol 1975; 2: 322–326
   PubMed Web of Science ®Google Scholar
• Caridis D T, Reinhold R B, Woodruff P WH, Fine J. Endotoxaemia in man. Lancet 1972; 1: 1381–1385
   PubMed Web of Science ®Google Scholar
• Cooperstock M S. Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemother 1974; 6: 422–425
   PubMed Web of Science ®Google Scholar
• Cooperstock M S, Riegle L. Polymyxin B inactivation of lipopolysaccharide in vaccines of gram-negative bacteria. Infect Immun 1981; 33: 315–318
   PubMedGoogle Scholar
• Ditter B, Urbaschek R, Urbaschek B. Ability of various absorbents to bind endotoxins in vitro and to prevent orally induced endotoxemia in mice. Gastroenterology 1983; 84: 1547–1552
   PubMed Web of Science ®Google Scholar
• Emmelot C H, van der Waaij D. The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice. J Hyg Camb 1980; 84: 331–340
   PubMedGoogle Scholar
• Gans H, Matsumoto K. The escape of endotoxin from the intestine. Surg Gynecol Obstet 1974; 139: 395–402
   PubMedGoogle Scholar
• Gardi A, Arpagaus G R. Improved microtechnique for endotoxin assay by the Limulus amebocyte lysate test. Anal Biochem 1980; 109: 382–385
   PubMed Web of Science ®Google Scholar
• Goss W A, Cimyotti E B. Evaluation of an automatic diluting device for microbiological applications. Appl Microbiol 1976; 16: 1414–1416
   Google Scholar
• Hazenberg M P, van de Boom M, Bakker M, van de Merwe J P. Effect of antibiotics on the human intestinal flora in mice. Antonie van Leeuwenhoek J Microbiol Serol 1982; 49: 97–109
   Google Scholar
• Hazenberg M P, van de Boom M, Bakker M, van de Merwe J P. Binding to faeces and influence on human anaerobes of antimicrobial agents for selective decontamination. Antonie van Leeuwenhoek J Microbiol Serol 1983; 49: 111–117
   PubMedGoogle Scholar
• Jacob A I, Goldberg P K, Bloom N, Degenshein A, Kozinn P J. Endotoxin and bacteria in portal blood. Gastroenterology 1978; 72: 1268–1270
   Web of Science ®Google Scholar
• Jorgensen J H, Smith R F. Measurement of bound and free endotoxin by the Limulus assay. Proc Soc Exp Biol Med 1974; 146: 1024–1031
   PubMed Web of Science ®Google Scholar
• Jules K, Neu H C. Antibacterial activity and β-lactamase stability of temocillin. Antimicrob Agents Chemother 1982; 22: 453–460
   PubMedGoogle Scholar
• Kasper D L. Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis 1976; 134: 59–66
   PubMed Web of Science ®Google Scholar
• Levin J, Poore E, Zauber N P, Oser R S. Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria. N Engl J Med 1970; 283: 1313–1316
   PubMed Web of Science ®Google Scholar
• Murray P R. Standardization of the Analytab. Enteric (API 20E) system to increase the accuracy and the reproducibility of the test for biotype characterization of bacteria. J Clin Microbiol 1978; 8: 46–49
   PubMed Web of Science ®Google Scholar
• Neu H C, Labthavikul P. Antibacterial activity of a monocyclic β-lactam SQ 26-776. J Antimicrob Chemother 1981; 8: 111–122, Suppl E
   PubMed Web of Science ®Google Scholar
• Prytz H, Holst-Christensen J, Korner B, Leihr H. Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol 1976; 11: 857–863
   PubMed Web of Science ®Google Scholar
• Rothfield L, Pearlman-Kothencz M. Synthesis and assembly of bacterial membrane components. A lipopolysaccharide-phospholipid-protein complex excreted by living baceteria. J Mol Biol 1969; 44: 477–492
   PubMed Web of Science ®Google Scholar
• Russel R RB. Free endotoxin-a review. Microbios Lett 1976; 2: 125–135
   Google Scholar
• Savage D C. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31: 107–133
   PubMed Web of Science ®Google Scholar
• Slocombe B, Baskec M J, Bently P H, Clayton J P, Cole M, Comber K R, Dixon R A, Edmondson R A, Jackson D, Merrikin D J, Sutherland R. BRL 17421, a novel β-lactam antibiotic, highly resistant to β-lactamase, giving high and prolonged serum levels in humans. Antimicrob Agents Chemother 1981; 20: 38–46
   PubMed Web of Science ®Google Scholar
• Swabb E A, Sugerman A A, Stern M. Bioavailability of the monolactam aztreonam (SQ 26.776) in healthy subjects. Antimicrob Agents Chemother 1983; 23: 548–550
   PubMedGoogle Scholar
• Vaara M. Polymyxin B nonapeptide complexes with lipopolysaccharide. FEMS Lett 1983; 18: 117–121
   Google Scholar
• van der Waaij D, Sturm C A. The production of “bacteria-free” mice. Relationship between fecal flora and bacterial population of the skin. Antonie van Leeuwenhoek J Microbiol Serol 1971; 37: 139–151
   PubMedGoogle Scholar
• van der Waaij D, Berghuis-de Vries J. Oral dose and faecal concentration of antibiotics during decontamination in mice and in a patient. J Hyg Camb 1974; 73: 197–203
   PubMedGoogle Scholar
• Wright W W, Welch H. Chemical, biological, and clinical observations on colistin. Antibiot Ann 1969/70; 61–74
   Google Scholar